Reuters logo
4 个月前
BRIEF-Champions Oncology posts Q3 adj. loss per share $0.11
2017年3月16日 / 晚上8点52分 / 4 个月前

BRIEF-Champions Oncology posts Q3 adj. loss per share $0.11

1 分钟阅读

March 16 (Reuters) - Champions Biotechnology Inc

* Champions Oncology reports 40 pct revenue growth

* Q3 revenue rose 39.7 percent to $3.6 million

* For Q3 of fiscal 2017, champions reported a loss from operations of $1.4 million

* Qtrly non-GAAP loss per share $ 0.11

* Qtrly GAAP loss per share $0.13

* Qtrly non-GAAP loss per share $0.11

* Champions Biotechnology Inc - company ended quarter with $3.5 million of cash and cash equivalents on balance sheet Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below